Robert Simmons
Analyst · Raymond James. Please go ahead
Today, we reported third quarter GAAP net income of $10 million or $0.19 diluted earnings per share. Adjusted net income for the third quarter was $74 million or $1.45 diluted earnings per share. Q3 pretax income was $14 million on a GAAP basis and $99 million on an adjusted basis. As outlined in the release, our adjusted income excludes a noncash impairment charge of $85 million before tax on our CRJ900 fleet that I will discuss further momentarily. Our diluted share count for Q3 was 50.7 million shares and our effective tax rate in Q3 was 31.9%. First, let's talk about revenue. Total Q3 revenue of $745 million is up 63% from Q3 2020 and is up 13% from last quarter. Q3 2021 revenue is only down 2% from Q3 2019 as the recovery continues. Our Q3 block hour production was up 14% sequentially from Q2 compared to the 13% sequential increase in revenue. Q3 revenue breaks down with contract revenue up 54% from Q3 2020 and up 12% from Q2. We have temporary partner revenue concessions impacting Q1, Q2 and Q3 of 2021 and in Q3 2020 for comparative purposes. Q3 was likely the last quarter with temporary revenue concessions. Prorate revenue was $128 million in Q3, up 111% year-over-year and up 24% from last quarter. Leasing and other revenue is up 107% year-over-year and 7% sequentially. These GAAP results include the effect of the release of $19 million of deferred revenue this quarter compared to $6 million deferred during Q2 and $30 million deferred in Q3 in '20. As of the end of Q3, we have $118 million of cumulative deferred revenue that will be recognized in future periods. As discussed last quarter, the timing and amount of future deferrals or reversals into revenue depends on the shape and cadence of the recovery of our flying. All deferred revenue will be reversed into revenue by the end of the various contract periods. Transitioning to our operating expenses. During Q3 $115 million in PSP grants was recognized as income in the form of a contra expense in our P&L. This compares to grant income of $193 million recognized in Q1 and $114 million in Q2. We do not expect any additional grant income in Q4 absent any PSP3 top-up amounts. As previously announced in August and highlighted in today's release, we reached an agreement with Delta to place 16 new E175 aircraft under a long-term contract. These E175 aircraft will replace 16 older SkyWest and CRJ900 aircraft we currently operate for Delta. Under this fleet transition, we are scheduled to have 16 displaced CRJ900s in 2022. Given the uncertainty of redeploying these displaced 900s, we reevaluated them for impairment which resulted in a noncash impairment charge of $85 million during the quarter. We expect depreciation expense on these aircraft will continue until the aircraft are removed from the Delta contract. The aggregate remaining debt and lease payment obligations on our finance of CRJ900s following the removal from the Delta contract are scheduled to be only $6 million. Let me move to the balance sheet. We ended the quarter with cash of $913 million, down from $956 million last quarter. Our CapEx during the third quarter was $162 million for six new E175 aircraft, one used CRJ700 aircraft, spare engines and other fixed assets. Our expectation for total 2021 CapEx is approximately $600 million to $620 million, including the purchase of 12 new E175s in the fourth quarter of this year under our previously announced contract with American. This compares to a $438 million in CapEx in 2020. We ended Q3 with debt of $3 billion, down from $3.2 billion as of year-end 2020. The only government debt we have on our balance sheet is a total of 201 million in PSP, 10 year unsecured, no amortization, low coupon loans. Let me say a couple of things about liquidity. As of September 30, 2021, our cash position of $913 million included the effect this quarter of having repaid an incremental $107 million of debt before adding $119 million of debt financing for the six new E175s. We also have approximately $1.5 billion of unpledged collateral that could be deployed for additional liquidity if ever needed. As of 9/30/2021, our debt net of cash balance is actually $421 million lower than it was pre-COVID at the end of 2019. Additional flexibility comes from the fact that including partner owned aircraft, over 50% of our fleet in service now has no financing obligation. Especially in times of great uncertainty like this and consistent with our policy and practice, we are not in a position to give any specific EPS guidance at this time. But let me give you a little color. First, we expect Q4 earnings to be roughly breakeven to slightly negative. The profit reduction from $99 million in Q3 adjusted pretax earnings to Q4 is comprised of several elements. Q4 is not expected to have any net PSP benefit, no grant income and no partner concessions. Although our block hour production in Q3 was in a couple of percentage points of Q3 2019 levels, we anticipate some softening in production schedules in Q4. Normal seasonality is expected to lower Q4 results from Q3, similar to pre-COVID patterns. Our prorate business is expected to also soften sequentially from Q3 to Q4. Prorate was only slightly profitable in Q3. Wade will talk more about this in a minute. Cancellations related to our server outage last week could end up costing us $15 million to $20 million in Q4. Second, we expect to return to 2019 production levels in 2022. 2022 maintenance expense is expected to be lower than 2021 but higher than 2019 but with some positive offsets in revenue. We won't see the full year impact of the 45 accretive new E175 aircraft until 2023, some impact in 2022. The impact in 2021 of the PSP grants net of partner concessions was a little over $200 million for the year. We're hoping to offset that in 2022 with normal operations. As a result, 2022 earnings may look similar to 2021, excluding the 2021 impairment charge. We believe that the actions we are taking now and expect to take over the next few quarters are setting us up nicely for the new normal in the future. Wade?